NEA Management Company, LLC Q4 2016 Filing
Filed February 9, 2017
Portfolio Value
$2.5T
Holdings
39
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 10,275,113 | $1.4T | 54.94% | |
| 2 | ARDXARDELYX INC | 14,083,582 | $200.0B | 7.95% | |
| 3 | —DERMIRA INC | 3,506,649 | $106.4B | 4.23% | |
| 4 | —EPIZYME INC | 6,260,851 | $75.8B | 3.01% | |
| 5 | SENS1GBPSENSEONICS HOLDINGS INC | 26,305,286 | $70.2B | 2.79% | |
| 6 | —ACHAOGEN INC | 5,215,125 | $67.9B | 2.70% | |
| 7 | GRPNCHFGROUPON INC | 20,075,762 | $66.7B | 2.65% | |
| 8 | CRSPCRISPR THERAPEUTICS AG | 3,220,728 | $65.3B | 2.59% | |
| 9 | —RA PHARMACEUTICALS INC | 3,493,636 | $53.1B | 2.11% | |
| 10 | GLYCEURGLYCOMIMETICS INC | 8,584,128 | $52.4B | 2.08% | |
| 11 | CLVSEURCLOVIS ONCOLOGY INC | 1,139,890 | $50.6B | 2.01% | |
| 12 | —PROTEOSTASIS THERAPEUTICS INC | 3,556,778 | $43.6B | 1.73% | |
| 13 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 9,880,999 | $40.0B | 1.59% | |
| 14 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $32.9B | 1.31% | |
| 15 | —CARE COM INC | 3,260,989 | $27.9B | 1.11% | |
| 16 | —AEROHIVE NETWORKS INC | 4,673,536 | $26.6B | 1.06% | |
| 17 | NVROEURNEVRO CORP | 359,678 | $26.1B | 1.04% | |
| 18 | —TREVENA INC | 3,811,691 | $22.4B | 0.89% | |
| 19 | —ENDOLOGIX INC | 2,490,204 | $14.2B | 0.57% | |
| 20 | —TRACON PHARMACEUTICALS INC | 2,759,217 | $13.5B | 0.54% | |
| 21 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $9.9B | 0.40% | |
| 22 | AUPHAURINIA PHARMACEUTICALS INC | 4,067,743 | $8.5B | 0.34% | |
| 23 | —CASCADIAN THERAPEUTICS INC | 1,791,666 | $7.7B | 0.31% | |
| 24 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $7.7B | 0.31% | |
| 25 | —AVEO PHARMACEUTICALS INC | 10,362,694 | $5.6B | 0.22% | |
| 26 | —MIRNA THERAPEUTICS INC | 2,974,811 | $5.4B | 0.21% | |
| 27 | —DASAN ZHONE SOLUTIONS INC | 4,781,290 | $4.7B | 0.19% | |
| 28 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $4.7B | 0.19% | |
| 29 | —ARCA BIOPHARMA INC | 1,460,209 | $4.2B | 0.17% | |
| 30 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $4.0B | 0.16% | |
| 31 | —ROKA BIOSCIENCE INC | 893,471 | $3.8B | 0.15% | |
| 32 | —AKARI THERAPEUTICS PLC | 452,167 | $3.2B | 0.13% | |
| 33 | —ARQULE INC | 2,520,316 | $3.2B | 0.13% | |
| 34 | —ZOSANO PHARMA CORP | 2,052,809 | $1.6B | 0.06% | |
| 35 | —PARATEK PHARMACEUTICALS INC | 66,245 | $1.0B | 0.04% | |
| 36 | —AGILE THERAPEUTICS INC | 133,488 | $761.0M | 0.03% | |
| 37 | —OREXIGEN THERAPEUTICS INC | 370,900 | $645.0M | 0.03% | |
| 38 | —CERECOR INC | 595,435 | $524.0M | 0.02% | |
| 39 | —CATALYST BIOSCIENCES INC | 652,380 | $424.0M | 0.02% |